XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Based Compensation (Tables)
3 Months Ended
Mar. 31, 2023
Stock Based Compensation  
Summary of Activity Related to Stock Options


 

Number of Options

(in thousands)

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term (Years)

 

Outstanding, January 1, 2023   

$

440

 

 

$

55.65

 

 

  

7.5

 

Granted

 

3

 

 

 

  

 

 

 

 

 

Exercised

 

 

 

 


 

 

 

 

 

Cancelled

 

(6

)

 

 

  

 

 

 

 

 

Outstanding, March 31, 2023

$

437


 

$

55.74



  

7.2


Exercisable, March 31, 2023

$

284

 

 

$

75.84

 

 

  

6.7

 

Summary of Activity Related to Restricted Stock and Deferred Stock Units Granted


 

 

Number of Shares

(in thousands)

 

 

Weighted Average Grant Date Fair Value

 

Nonvested, January 1, 2023

 

 

127

 

 

$

11.85

 

Granted

 

 

 

 

 


 

Vested

 

 

(4

)

 

 


 

Cancelled

 

 

 

 


 

Nonvested, March 31, 2023

 

 

123

 

 

$

11.81

 

Schedule of Recognized Stock Compensation for Equity Awards


 



Three months ended March 31,

(in thousands) 


2023


2022

Selling, general and administrative


$ 510

$ 705

Research and development



57


66

Cost of goods sold



5


6
Total expense 
$ 572

$ 777
Summary of Weighted Average Assumptions Used in Valuing Plans



Three months ended March 31,


2023



2022

Fair value at grant date

$

3.46

 


$ 8.10

Expected volatility

114.0



84.0
 

Risk-free interest rate

3.9



1.6 %

Expected holding period, in years

6.0

 



6.0

Dividend yield

 



%